Rotten Tomato Stocks
No Result
View All Result
  • News
    First Majestic Shares Drop After Mining at Nevada Operation Suspended

    First Majestic Shares Drop After Mining at Nevada Operation Suspended

    Wheat Futures Fall After Export Deal Reached

    Wheat Futures Fall After Export Deal Reached

    Toyota Industries Shares Slump After It Suspends Shipments of Certain Forklifts

    Toyota Industries Shares Slump After It Suspends Shipments of Certain Forklifts

    Lumen’s stock follows record annual decline with another steep plunge this year

    Lumen’s stock follows record annual decline with another steep plunge this year

  • NYSE
    Is ServiceNow (NYSE:NOW) Using Too Much Debt?

    Is ServiceNow (NYSE:NOW) Using Too Much Debt?

    McDonald’s Corp. stock falls Tuesday, underperforms market

    McDonald’s Corp. stock falls Tuesday, underperforms market

    Burford Capital (NYSE:BUR) Trading Down 5.3% Following Analyst Downgrade

    Burford Capital (NYSE:BUR) Trading Down 5.3% Following Analyst Downgrade

    Credit Suisse shares slump by two-thirds after UBS deal

    Credit Suisse shares slump by two-thirds after UBS deal

  • NASDAQ
    Check-Cap Falls 43% After C-Scan Study Update

    Check-Cap Falls 43% After C-Scan Study Update

    Equinix Inc. stock falls Tuesday, underperforms market

    Equinix Inc. stock falls Tuesday, underperforms market

    Halozyme Therapeutics (NASDAQ:HALO) Hits New 12-Month Low on Analyst Downgrade

    Halozyme Therapeutics (NASDAQ:HALO) Hits New 12-Month Low on Analyst Downgrade

    Aziyo Biologics Shares Fall to New Low After FDA Rejection

    Aziyo Biologics Shares Fall to New Low After FDA Rejection

  • OTC
    China Eastern Airlines 3Q Loss Widens on Low Travel Demand

    China Eastern Airlines 3Q Loss Widens on Low Travel Demand

    Corus Entertainment 4Q Profit Falls

    Corus Entertainment 4Q Profit Falls

    Nintendo Co. Ltd. ADR falls Monday, still outperforms market

    Nintendo Co. Ltd. ADR falls Monday, still outperforms market

    Ocado Group PLC Revenue of Ocado Retail in Q3 Fell 10.6%

    Ocado Group PLC Revenue of Ocado Retail in Q3 Fell 10.6%

  • TSX
    US Seeks to Fine Air Canada $25.5 Million Over Slow Refunds

    US Seeks to Fine Air Canada $25.5 Million Over Slow Refunds

    S&P/TSX composite falls on drop in materials sector, loonie tops 81 cents US

    S&P/TSX composite falls on drop in materials sector, loonie tops 81 cents US

    Bitcoin Is Falling: Should You Buy the Dip?

    Bitcoin Is Falling: Should You Buy the Dip?

    CN Rail Stock Is So Undervalued That it’s Absurd

    CN Rail Stock Is So Undervalued That it’s Absurd

  • News
    First Majestic Shares Drop After Mining at Nevada Operation Suspended

    First Majestic Shares Drop After Mining at Nevada Operation Suspended

    Wheat Futures Fall After Export Deal Reached

    Wheat Futures Fall After Export Deal Reached

    Toyota Industries Shares Slump After It Suspends Shipments of Certain Forklifts

    Toyota Industries Shares Slump After It Suspends Shipments of Certain Forklifts

    Lumen’s stock follows record annual decline with another steep plunge this year

    Lumen’s stock follows record annual decline with another steep plunge this year

  • NYSE
    Is ServiceNow (NYSE:NOW) Using Too Much Debt?

    Is ServiceNow (NYSE:NOW) Using Too Much Debt?

    McDonald’s Corp. stock falls Tuesday, underperforms market

    McDonald’s Corp. stock falls Tuesday, underperforms market

    Burford Capital (NYSE:BUR) Trading Down 5.3% Following Analyst Downgrade

    Burford Capital (NYSE:BUR) Trading Down 5.3% Following Analyst Downgrade

    Credit Suisse shares slump by two-thirds after UBS deal

    Credit Suisse shares slump by two-thirds after UBS deal

  • NASDAQ
    Check-Cap Falls 43% After C-Scan Study Update

    Check-Cap Falls 43% After C-Scan Study Update

    Equinix Inc. stock falls Tuesday, underperforms market

    Equinix Inc. stock falls Tuesday, underperforms market

    Halozyme Therapeutics (NASDAQ:HALO) Hits New 12-Month Low on Analyst Downgrade

    Halozyme Therapeutics (NASDAQ:HALO) Hits New 12-Month Low on Analyst Downgrade

    Aziyo Biologics Shares Fall to New Low After FDA Rejection

    Aziyo Biologics Shares Fall to New Low After FDA Rejection

  • OTC
    China Eastern Airlines 3Q Loss Widens on Low Travel Demand

    China Eastern Airlines 3Q Loss Widens on Low Travel Demand

    Corus Entertainment 4Q Profit Falls

    Corus Entertainment 4Q Profit Falls

    Nintendo Co. Ltd. ADR falls Monday, still outperforms market

    Nintendo Co. Ltd. ADR falls Monday, still outperforms market

    Ocado Group PLC Revenue of Ocado Retail in Q3 Fell 10.6%

    Ocado Group PLC Revenue of Ocado Retail in Q3 Fell 10.6%

  • TSX
    US Seeks to Fine Air Canada $25.5 Million Over Slow Refunds

    US Seeks to Fine Air Canada $25.5 Million Over Slow Refunds

    S&P/TSX composite falls on drop in materials sector, loonie tops 81 cents US

    S&P/TSX composite falls on drop in materials sector, loonie tops 81 cents US

    Bitcoin Is Falling: Should You Buy the Dip?

    Bitcoin Is Falling: Should You Buy the Dip?

    CN Rail Stock Is So Undervalued That it’s Absurd

    CN Rail Stock Is So Undervalued That it’s Absurd

No Result
View All Result
Rotten Tomato Stocks
No Result
View All Result

Incyte (NASDAQ:INCY) Stock Price Down 5.5% on Disappointing Earnings

Editorial Staff by Editorial Staff
February 8, 2022
0
Incyte (NASDAQ:INCY) Stock Price Down 5.5% on Disappointing Earnings

Incyte Co. (NASDAQ:INCY) was down 5.5% during trading on Tuesday following a weaker than expected earnings announcement. The company traded as low as $69.17 and last traded at $69.31. Approximately 21,780 shares changed hands during trading, a decline of 99% from the average daily volume of 1,866,927 shares. The stock had previously closed at $73.35.The biopharmaceutical company reported $0.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.86 by ($0.76). The firm had revenue of $862.50 million during the quarter, compared to the consensus estimate of $813.38 million. Incyte had a return on equity of 22.27% and a net margin of 18.35%. The company’s quarterly revenue was up 9.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.73 EPS.


A number of analysts have recently issued reports on INCY shares. Royal Bank of Canada raised shares of Incyte from a “sector perform” rating to an “outperform” rating and increased their price objective for the stock from $78.00 to $90.00 in a research note on Tuesday, January 18th. BMO Capital Markets started coverage on shares of Incyte in a research note on Thursday, November 18th. They issued a “market perform” rating and a $75.00 price objective for the company. Guggenheim reduced their price objective on shares of Incyte from $118.00 to $104.00 in a research note on Monday, January 3rd. Morgan Stanley reduced their price objective on shares of Incyte from $77.00 to $76.00 and set an “equal weight” rating for the company in a research note on Wednesday, February 2nd. Finally, Oppenheimer reduced their price objective on shares of Incyte from $110.00 to $109.00 and set an “outperform” rating for the company in a research note on Wednesday, November 3rd. One investment analyst has rated the stock with a sell rating, three have given a hold rating and six have given a buy rating to the company. Based on data from MarketBeat, Incyte presently has a consensus rating of “Buy” and a consensus target price of $89.20.

In other Incyte news, EVP Jonathan Elliott Dickinson sold 7,375 shares of the stock in a transaction that occurred on Monday, January 31st. The shares were sold at an average price of $74.19, for a total value of $547,151.25. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, Director Wendy L. Dixon sold 20,000 shares of the firm’s stock in a transaction that occurred on Thursday, December 23rd. The stock was sold at an average price of $22.05, for a total transaction of $441,000.00. The disclosure for this sale can be found here. Insiders have sold 38,245 shares of company stock valued at $1,785,031 in the last ninety days. Insiders own 15.80% of the company’s stock.

Institutional investors and hedge funds have recently bought and sold shares of the business. Vanguard Group Inc. boosted its position in shares of Incyte by 0.3% during the 2nd quarter. Vanguard Group Inc. now owns 20,470,534 shares of the biopharmaceutical company’s stock valued at $1,722,186,000 after purchasing an additional 60,751 shares in the last quarter. BlackRock Inc. grew its stake in shares of Incyte by 2.7% in the third quarter. BlackRock Inc. now owns 17,411,778 shares of the biopharmaceutical company’s stock worth $1,197,584,000 after acquiring an additional 460,500 shares during the last quarter. Dodge & Cox boosted its stake in Incyte by 214.9% during the second quarter. Dodge & Cox now owns 13,597,536 shares of the biopharmaceutical company’s stock worth $1,143,961,000 after buying an additional 9,280,144 shares in the last quarter. State Street Corp lifted its holdings in shares of Incyte by 1.1% during the second quarter. State Street Corp now owns 8,441,379 shares of the biopharmaceutical company’s stock valued at $710,173,000 after acquiring an additional 90,130 shares during the period. Finally, Geode Capital Management LLC raised its holdings in shares of Incyte by 5.5% in the third quarter. Geode Capital Management LLC now owns 3,825,719 shares of the biopharmaceutical company’s stock valued at $262,527,000 after buying an additional 199,662 shares during the last quarter. Institutional investors own 91.06% of the company’s stock.

The company has a debt-to-equity ratio of 0.01, a quick ratio of 3.91 and a current ratio of 3.94. The company has a 50-day moving average price of $72.09 and a 200-day moving average price of $71.15. The company has a market capitalization of $15.06 billion, a price-to-earnings ratio of 30.44, a price-to-earnings-growth ratio of 0.63 and a beta of 0.70.

Incyte Company Profile (NASDAQ:INCY)

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development and commercialization of proprietary therapeutics. Its portfolio includes compounds in various stages, ranging from preclinical to late stage development, and commercialized products such as JAKAFI (ruxolitinib), and ICLUSIG (ponatinib).

Related Posts

Check-Cap Falls 43% After C-Scan Study Update
NASDAQ

Check-Cap Falls 43% After C-Scan Study Update

March 22, 2023
Equinix Inc. stock falls Tuesday, underperforms market
NASDAQ

Equinix Inc. stock falls Tuesday, underperforms market

March 22, 2023
Halozyme Therapeutics (NASDAQ:HALO) Hits New 12-Month Low on Analyst Downgrade
NASDAQ

Halozyme Therapeutics (NASDAQ:HALO) Hits New 12-Month Low on Analyst Downgrade

March 22, 2023
Aziyo Biologics Shares Fall to New Low After FDA Rejection
NASDAQ

Aziyo Biologics Shares Fall to New Low After FDA Rejection

March 21, 2023
Load More
Next Post
Is Qurate Retail (NASDAQ:QRTE.A) Using Too Much Debt?

Is Qurate Retail (NASDAQ:QRTE.A) Using Too Much Debt?

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

I agree to the Terms & Conditions and Privacy Policy.

POPULAR NEWS

CNH Industrial (NYSE:CNHI) Use Of Debt Could Be Considered Risky

CNH Industrial (NYSE:CNHI) Use Of Debt Could Be Considered Risky

April 14, 2021
CN Rail Stock Is So Undervalued That it’s Absurd

CN Rail Stock Is So Undervalued That it’s Absurd

May 2, 2021
US Seeks to Fine Air Canada $25.5 Million Over Slow Refunds

US Seeks to Fine Air Canada $25.5 Million Over Slow Refunds

June 17, 2021
Ocado Group PLC Revenue of Ocado Retail in Q3 Fell 10.6%

Ocado Group PLC Revenue of Ocado Retail in Q3 Fell 10.6%

September 14, 2021
10 Warning Signs That Should Tell You “This Stock is in Trouble”

10 Warning Signs That Should Tell You “This Stock is in Trouble”

November 11, 2019

EDITOR'S PICK

Is ViewRay (NASDAQ:VRAY) Using Debt Sensibly?

Is ViewRay (NASDAQ:VRAY) Using Debt Sensibly?

August 10, 2021
NIO Shares Slump After Fourth-Quarter Loss Widens

NIO Shares Slump After Fourth-Quarter Loss Widens

March 1, 2023
S&P 500, Nasdaq fall but stock market internals stay firmly bullish

S&P 500, Nasdaq fall but stock market internals stay firmly bullish

August 8, 2022
Is Entergy (NYSE:ETR) Using Too Much Debt?

Is Entergy (NYSE:ETR) Using Too Much Debt?

September 27, 2021

Stay Updated

Get breaking news delivered straight into your inbox

Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Rotten Tomato stocks is a wholly-owned subsidiary of Grainne Capital Limited.
While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

Rotten Tomato Stocks cover the companies and markets that are declining, failing or headed for disaster. We help investors spot the down tends and recognize when something smells rotten.

RECENT POSTS

First Majestic Shares Drop After Mining at Nevada Operation Suspended

Is ServiceNow (NYSE:NOW) Using Too Much Debt?

McDonald’s Corp. stock falls Tuesday, underperforms market

POPULAR POSTS

Burford Capital (NYSE:BUR) Trading Down 5.3% Following Analyst Downgrade

Check-Cap Falls 43% After C-Scan Study Update

Equinix Inc. stock falls Tuesday, underperforms market

© Copyright 2023 RottenTomatoStocks. All Rights Reserved 

Disclaimer | Privacy Policy

No Result
View All Result
  • HOME
  • NEWS
  • NYSE
  • NASDAQ
  • OTC
  • TSX

© 2021 RottenTomatoStocks.com

error: Content is protected !!
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.